Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07441382Recruiting
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Net Adverse Clinical Events at 12 months. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07441382.